Produktbild: Neuropsychiatric and Cognitive Changes in Parkinson's Disease and Related Movement Disorders

Neuropsychiatric and Cognitive Changes in Parkinson's Disease and Related Movement Disorders Diagnosis and Management

149,99 €

inkl. gesetzl. MwSt., Versandkostenfrei


Beschreibung

Produktdetails

Einband

Gebundene Ausgabe

Erscheinungsdatum

29.08.2013

Herausgeber

Aarsland Dag + weitere

Verlag

Cambridge University Press

Seitenzahl

307

Maße (L/B/H)

24,9/18,5/2 cm

Gewicht

900 g

Sprache

Englisch

ISBN

978-1-107-03922-3

Beschreibung

Rezension

'This is a first-rate book on the neuropsychiatry of Parkinson's disease. It should be required reading for clinicians who are involved in the treatment of patients with this illness.' Doody's Notes

Produktdetails

Einband

Gebundene Ausgabe

Erscheinungsdatum

29.08.2013

Herausgeber

Verlag

Cambridge University Press

Seitenzahl

307

Maße (L/B/H)

24,9/18,5/2 cm

Gewicht

900 g

Sprache

Englisch

ISBN

978-1-107-03922-3

Herstelleradresse

Libri GmbH
Europaallee 1
36244 Bad Hersfeld
DE

Email: gpsr@libri.de

Noch keine Bewertungen vorhanden

Verfassen Sie die erste Bewertung zu diesem Artikel

Helfen Sie anderen Kundinnen und Kunden durch Ihre Meinung.

Kundinnen und Kunden meinen

Bewertungen (0)

Die Leseprobe wird geladen.
  • Produktbild: Neuropsychiatric and Cognitive Changes in Parkinson's Disease and Related Movement Disorders
  • Preface; Part I. General Aspects: 1. Overview of Parkinson's disease: epidemiology, diagnosis, course, medical and surgical management Sheila S. Rane and Christopher G. Goetz; 2. Parkinson's disease: pathology, anatomy, and behavior James B. Leverenz and Daniel J. Burdick; 3. Genetics and behavior and cognition in Parkinson's disease Caroline H. Williams-Gray and Roger A. Barker; 4. The boundaries of Parkinson's disease dementia and dementia with Lewy bodies Elisabet Londos; Part II. Diagnosis and Biomarkers: 5. Cognitive assessment in Parkinson's disease Jaime Kulisevsky, Saül Martínez-Horta and Javier Pagonabarraga; 6. Clinical assessment: mood and motivation Albert F. G. Leentjens; 7. Imaging and behavior in Parkinson's disease: structural imaging Mona K. Beyer, Turi O. Dalaker and Liana G. Apostolova; 8. Imaging and behavior in Parkinson's disease: functional imaging Agneta Nordberg; 9. Diagnosis and biomarkers: CSF Brit Mollenhauer and Henrik Zetterberg; Part III. Specific Neuropsychiatric Disorders: 10. Depression Per Svenningsson and Dag Aarsland; 11. Anxiety Laura Marsh and Jessica Calleo; 12. Apathy Kathy Dujardin; 13. Impulse control disorder Daniel Weintraub and Irena Rektorova; 14. Hallucinations and psychosis Oscar Bernal-Pacheco and Hubert H. Fernandez; 15. Early cognitive impairment Alexander I. Tröster and Dag Aarsland; 16. Parkinson's disease dementia: features and management Basar Bilgiç, Hasmet A. Hanagasi and Murat Emre; 17. Sleep disturbances Pouya Movahed, Kristina Røkenes Karlsen and K. Ray Chaudhuri; Part IV. Management: 18. Parkinson's disease: drug treatment and behavior Jaime Kulisevsky, Javier Pagonabarraga and Carolina Villa-Bonomo; 19. Surgical treatments and behavior Jens Volkmann and Christine Daniels; 20. Clinical trials for psychotropic agents in Parkinson's diesase using psychosis as a model Ryan R. Walsh and Jeffrey Cummings; Part V. Other Issues: 21. Clinical implications of neuropsychiatric symptoms in Parkinson's disease Angelo Antonini and Pablo Martinez-Martin; 22. Neuropsychiatric and cognitive disorders in other Parkinsonian disorders Adam Gerstenecker, Benjamin T. Mast and Irene Litvan; 23. Neuropsychiatric aspects of the on-off phenomenon Irene Rektorova and Marek Balaz; 24. Treatment of neuropsychiatric disturbances in Parkinson's disease: future prospects and strategies Jeffery Cummings and Dag Aarsland; Index.